Creative Peptides Competitors and Similar CompaniesClear all
Creative Peptides's competitors and similar companies include Ajinomoto Bio-Pharma Services, Gubra, Regeneron Pharmaceuticals and Bellus Health.
 Creative Peptides Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. |  Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO). |  Gubra Gubra is a biotech company that provides drug discovery programs and pre-clinical contract research services. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. |  Bellus Health Bellus Health is a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. | |
Founding Date | Founding Date N/A | Founding Date 1998 | Founding Date 2008 | Founding Date 1988 | Founding Date 2010 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Shirley, US HQ | Locations San Diego, US HQ Wetteren, BE Visakhapatnam, IN Osaka, JP | Locations Hørsholm, DK HQ | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Laval, CA HQ |
Employees | Employees 2 | Employees 68610% decrease | Employees 2672% increase | Employees 15,1068% increase | Employees 7485% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr2.6b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $16k (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods kr73.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit kr2.6b (FY, 2025) | Gross profit N/A | Gross profit $507k (FY, 2022) |
Net income | Net income N/A | Net income N/A | Net income kr1.7b (FY, 2025) | Net income $4.5b (FY, 2025) | Net income ($76.1m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 3.5m | Total funding raised N/A | Total funding raised $ 53.9m | Total funding raised $ 49.3m |
For sources of this data, please see the company profile
View Company Profiles
Ajinomoto Bio-Pharma Services
HQ
San Diego, US
Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO).
View companyGubra
HQ
Hørsholm, DK
Employees
267↑ 2% increase
Gubra is a biotech company that provides drug discovery programs and pre-clinical contract research services.
View companyRegeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
15,106↑ 8% increase
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View companyBellus Health
HQ
Laval, CA
Bellus Health is a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of chronic cough and other hypersensitization disorders.
View company